3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Neoplasms
6
Colorectal Neoplasms
4
Lung Neoplasms
3
Breast Neoplasms
3
Uterine Cervical Neoplasms
2
Prostatic Neoplasms
2
Pain
2
Motor Activity
2
Hematopoietic and Lymphatic System Neoplasm
2
Carcinoma, Non-Small-Cell Lung
2
Breast Carcinoma In Situ
2
Squamous Cell Carcinoma of Head and Neck
1
Smoking Cessation
1
Sedentary Behavior
1
Sarcoma
1
Recurrence
1
Pyloric Stenosis, Hypertrophic
1
Pulmonary Disease, Chronic Obstructive
1
Polyps
1
Papillomavirus Infections
1
Ovarian Neoplasms
1
Neoplasm Metastasis
1
Myelodysplastic Syndromes
1
Metastatic Pancreatic Adenocarcinoma
1
Malignant Hepatobiliary Neoplasm
1
Lymphoma, Non-Hodgkin
1
Leukemia, Myeloid, Acute
1
Insulin Resistance
1
Hodgkin Disease
1
Hereditary Breast and Ovarian Cancer Syndrome
1
Interventions
Dexamethasone
4
XENP 1595
2
Electroencephalography
2
selinexor
1
pomalidomide
1
ixazomib
1
fasudil
1
birtamimab
1
UE2343
1
Telemedicine
1
Tablets
1
Standard of Care
1
Rosiglitazone
1
Propofol
1
Positron-Emission Tomography
1
Methods
1
Melphalan
1
Mass Screening
1
Magnetic Resonance Imaging
1
Lysine Acetyltransferase 5
1
Hypnosis
1
Hormones
1
Exercise
1
Ethanol
1
Donepezil
1
Cyclophosphamide
1
Control Groups
1
Calcium Dobesilate
1
Bortezomib
1
Blood Specimen Collection
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Alzheimer Disease
×
Telemedicine
×
Clear all
NCT07332377
2026-03-18
PsyMINT
Virginia Commonwealth University
Phase NA
Recruiting
25 enrolled